Assessment of the frequency of different borrelia burgdorferi sensu lato species in patients with lyme borreliosis from north-east poland by studying preferential serologic response and DNA isolates

Annals of Agricultural and Environmental Medicine

Volumn 20, Issue 1, 2013, Pages 21-29

  Grygorczuk, Sambor ^a   Péter, Olivier ^b   Kondrusik, Maciej ^a   Moniuszko, Anna ^a   Zajkowska, Joanna ^a   Dunaj, Justyna ^a   Zukiewicz Sobczak, Wioletta ^c   Pancewicz, Slawomir ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Central Institute of the Valais Hospitals   (Switzerland)

^c INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Aetiology; Borrelia afzelii; Borrelia burgdorferi sl; Genotyping; Lyme borreliosis; Serologic typing

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA;

ACRODERMATITIS CHRONICA ATROPHICANS; ADULT; AGED; ARTHRITIS; ARTICLE; BACTERIUM IDENTIFICATION; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; ERYTHEMA CHRONICUM MIGRANS; FEMALE; GENOTYPE; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; POLAND; SEROTYPING;

ADULT; AGED; BORRELIA BURGDORFERI GROUP; DNA, BACTERIAL; FEMALE; GENOTYPE; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; POLAND; SEROLOGIC TESTS;

BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA BURGDORFERI GROUP;

EID: 84875613974     PISSN: 12321966     EISSN: 18982263     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol. 2007; 49(1): 13-21.
2. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ. Steere AC, Klempner MS, et al. The clinical assessment, treatment and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006; 43(9): 1089-1133.
3. Jones KL, Muellegger RR, Means TK, Lee M, Glickstein LJ, Damle N, et al. Higher nRNA levels of chemokines and cytokines associated with macrophage activation in erythema migrans skin lesions in patients from the United States than in patients from Austria with Lyme borreliosis. Clin Infect Dis. 2008; 46(1): 85-92.
4. Strle F, Ružić-Sabljić E, Cimperman J, Lotrič-Furlan S, Maraspin V. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin Infect Dis. 2006; 43(6): 704-710.
5. Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med. 1999; 130(1): 32-36.
6. Saint Girons I, Gern I, Gray JS, Guy EC, Korenberg E, Nuttall PA, etal. Identification of Borrelia burgdorferi sensu lato species in Europe. Zentralbl Bakteriol. 1998; 287(3): 190-195.
7. Hubalek Z, Halouzka J. Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review. Europ J Epidemiol. 1997; 13: 951-957.
8. Kirstein F, Rijpkema S, Molkenboer M, Gray JS. The distribution and prevalence of B.burgdorferi genomospecies in Ixodes ricinus ticks in Ireland. Eur J Epidemiol. 1997; 13(8): 67-72.
9. Oehme R, Hartelt K, Backe H, Brockmann S, Kimmig P. Foci of tick-borne diseases in southwest Germany. Int J Med Microbiol. 2002; 291 (Suppl 33): 22-29.
10. Stanek G, Reiter M. The expanding Lyme Borrelia complex - clinical significance of genomic species? Clin Microb Infect Dis. 2011; 17(4): 487-493.
11. Dam van AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, Spanjaard L, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis. 1993; 17(4): 708-717.
12. Demaerschalck I, Ben Messaud A, de Kesel M, Hoyois B, Lobet Y, Hoet P, et al. Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients. J Clin Microbiol. 1995; 33(3): 602-608.
13. Richter D, Schlee DB, Allgöwer R, Matuschka FR. Relationships of a novel Lyme disease spirochete, Borrelia spielmani sp. nov., with its hosts in Central Europe. Appl Environ Microbiol. 2004; 70(11): 6414-6419.
14. Rijpkema SG, Tazelaar DJ, Molkenboer MJ, Noordhoek GT, Plantinga G, Schouls LM, et al. Detection of Borrelia afzelii, Borrelia burgdorferi sensu stricto, Borrelia garinii and group VS116 by PCR in skin biopsies of patients with erythema migrans and acrodermatitis chronic atrophicans. Clin Microbiol Infect. 1997; 3(1): 109-116.
15. Stefanoff P, Rosińska M, Zieliński A. Epidemiology of tick-borne diseases in Poland. Przegl Epidemiol. 2006; 60(Suppl): 151-159 (in Polish).
16. Stańczak J, Kubica-Biernat B, Racewicz M, Kruminis-Lozowska W, Kur J. Detection of three genospecies of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks collected in different regions of Poland. Int J Med Microbiol. 2000; 290(6): 559-566.
17. Cisak E, Wójcik-Fatla A, Stojek NM, Chmielewska-Badora J, ZwolińskiJ, Buczek A, et al. Prevalence of Borrelia burgdorferi genospecies in Ixodes ricinus ticks from Lublin region (eastern Poland). Ann Agric Environ Med. 2006; 13(2): 301-306.
18. Lenčaková D, Hizo-Teufel C, Pet'ko B, Schulte-Spechtel U, Stanko M, Wilske B, et al. Prevalence of Borrelia burgdorferi s.l. OspA types in Ixodes ricinus ticks from selected localities in Slovakia and Poland. Int J Med Microbiol. 2006;296 (Suppl 40): 108-118.
19. Kondrusik M, Dunaj J, Pancewicz SA, Zajkowska JM, MoniuszkoA, Czupryna P, et al. Evaluation of Borrelia spp. prevalence and genospecies distribution among Ixodes ricinus ticks using Reverse-Line blot hybridization method. 12th International Conference on Lyme Borreliosis and Other Tick-Borne Diseases, September 26-29, 2010, Ljubljana, Slovenia. Abstracts. P 45-62.
20. Norman GL, Antig JM, Bigaignon G, Hogrefe WR. Serodiagnosis of Lyme borreliosis by Borrelia burgdorferi sensu stricto, B.garinii and B.afzelii Western blots (immunoblots). J Clin Microbiol. 1996; 34(7): 1732-1738.
21. Nygård K, Brantæter AB, Mehl R. Disseminated and chronic Lyme borreliosis in Norway, 1995-2004. Euro Surveill. 2005; 10(10): 235-238.
22. Ryffel K, Péter O, Rutti B, Suard A, Dayer E. Scored antibody reactivity determined by immunobloting shows an association between clinical manifestation and presence of Borrelia burgdorferi sensu stricto, B. garinii, B. afzelii, and B. valaisiana in humans. J Clin Microbiol. 1999; 37(12): 4086-4092.
23. Péter O, Bretz AG, Postic D, Dayer E. Association of distinct species of Borrelia burgdorferi sensu lato with neuroborreliosis in Switzerland. Clin Microbiol Infect. 1997; 3(4): 423-431.
24. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2005; 18(3): 484-509.
25. Rauter C, Oehme R, Diterich I, Engele M, Hartnung T. Distribution of clinically relevant Borrelia genospecies in ticks associated by a novel, single-run, real-time PCR. J Clin Microbiol. 2002; 40(1): 36-43.
26. Ranka R, Bormane A, Salmina K, Baumanis V. Identification of three clinically relevant Borrelia burgdorferi sensu lato genospecies by PCR-restriction fragment length polymorphism analysis of 16S-23S ribosomal DNA spacer amplicons. J Clin Microbiol. 2004; 42(14): 1444-1449.
27. Galdakaite E, Radzijevskaja J, Paulauskas A. Identification of Borrelia burgdorferi s.l. and Anaplasma phagocytophilum in I. ricinus and I. persulcatus ticks collected in Baltic countries. XI International Symposium on Tick-Borne Diseases 2011 (Formerly IPS). Program and Abstracts. P 20-88.
28. Wormser GP, Brisson D, Liveris D, Hanincová K, Sandigursky S, Nowakowski J, et al. Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis. 2008; 198(9): 1358-1364.
29. Steere AC. Clinical definitions and differential diagnosis of Lyme arthritis. Scand J Infect Dis. 1991; 23(Suppl.77): 51-4.